Antigen delivery compositions and methods of use

Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C977S907000

Reexamination Certificate

active

11121840

ABSTRACT:
The present invention provides antigen delivery compositions and methods of using same to prevent or to treat cancers and other infectious diseases.

REFERENCES:
patent: 5264618 (1993-11-01), Felgner et al.
patent: 5334761 (1994-08-01), Gebeyehu et al.
patent: 5459127 (1995-10-01), Felgner et al.
patent: 6008202 (1999-12-01), Huang et al.
patent: 6586409 (2003-07-01), Wheeler
patent: 6649170 (2003-11-01), Lindblad et al.
patent: 6693086 (2004-02-01), Dow et al.
patent: 6710035 (2004-03-01), Felgner et al.
patent: 6780421 (2004-08-01), Haensler et al.
patent: 7001614 (2006-02-01), Smyth-Templeton et al.
patent: 7105574 (2006-09-01), Wheeler
patent: 2003/0008813 (2003-01-01), Felgner et al.
patent: 2005/0245446 (2005-11-01), Hailes et al.
patent: 2006/0051405 (2006-03-01), MacLachlan et al.
patent: 2006/0083780 (2006-04-01), Heyes et al.
patent: 2006/0165708 (2006-07-01), Mayumi et al.
patent: 2006/0182793 (2006-08-01), Bachmann et al.
patent: 2006/0204566 (2006-09-01), Smyth-Templeton et al.
patent: 2006/0223769 (2006-10-01), Dow et al.
patent: 2006/0275777 (2006-12-01), Waelti
patent: 2007/0059318 (2007-03-01), Balu-lyer et al.
patent: 03095641 (2003-11-01), None
Steller et al. Clinical Cancer Research, 1998, vol. 4, pp. 2103-2109.
Dileo, et al., “Lipid-Protamine-DNA-Medicated Antigen Delivery to Antigen-Presenting Cells Results in Enhanced Anti-tumor Immune Responses”, Molecular Therapy, vol. 7, No. 5, (May 2003) pp. 640-648.
Cui, et al., “Immunostimulation Mechanism of LPD Nanoparticle as a Vaccine Carrier”, Molecular Pharmaceutics, vol. 2, No. 1, (Dec. 14, 2004) pp. 22-28.
Chen and Huang, “Cationic Liposome-based Peptide Vaccine: Potent Therapeutics for Cervical Cancer”, Poster, May 20, 2006.
Brunel, et al., Cationic Lipid DC-Chol Induces an Improved and Balanced Immunity Able to Overcome the Unresponsiveness to the Hepatitis B Vaccine, Vaccine, Apr. 1999, 2192-2203, vol. 17.
Walker, et al., Cationic Lipids Direct a Viral Glycoprotein into the Class I Major Histocompatibility Complex Antigen-Presentation Pathway, Proc. Natl. Acad. Sci. USA, Sep. 1992, 7915-7918, vol. 89.
Joseph, et al., A New Intranasal Influenza Vaccine Based on a Novel Polycationic Lipid-Ceramide Carbamoyl-Spermine (CCS) I. Immunogenicity and Efficacy Studies in Mice, Vaccine, 2006, 3990-4006, vol. 24.
Jiao, et al., Modulation of Cellular Immune Response Against Hepatitis C Virus Nonstructural Protein 3 by Cationic Liposome Encapsulated DNA Immunization, Hepatology, Feb. 2003, 452-460. vol. 37, No. 2.
Yasuda, et al., Endosomal Translocation of Vertebrate DNA Activates Dendritic Cells via TLR9-Dependant and Independent Pathways, The Journal of Immunology, 2005, 6129-6136, vol. 174.
Holten-Andersen, et al., Combination of the Cationic Surfactant Dimethyl Dioctadecyl Ammonium Bromide and Synthetic Mycobacterial Cord Factor as an Efficient Adjuvant for Tuberculosis Subunit Vaccines, Infection and Immunity, Mar. 2004, 1608-1617, vol. 72, No. 3.
Sprott, et al., Activation of Dentritic Cells by Liposomes Prepared from Phosphatidylinositol Mannosides from Mycobacterium Bovis Bacillus Calmette-Guerin and Adjuvant Activity In Vivo, Infection and Immunity, Sep. 2004, 5235-5246, vol. 72, No. 9.
Zaks, et al., Efficient Immunization and Cross-Priming by Vaccine Adjuvants Containing TLR3 or TLR9 Agonists Complexed to Cationic Liposomes, The Journal of Immunology, 2006, 7335-7345, vol. 176.
Korsholm, Unravelling the Adjuvant Mechanism of Cationic Liposomes, Statens Serum Institut, Jun. 2006, 15.00-15.30.
Rughetti, et al., Transfected Human Dendritic Cells to Induce Antitumor Immunity, Sep. 2000, 1458-1466, vol. 7, No. 17.
Cui, et al., Coating of Mannan on LPD Particles Containing HPV E7 Peptide Significantly Enhances Immunity Against HPV-Positive Tumor, Jun. 2004, 1018-1025, vol. 21, No. 6.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Antigen delivery compositions and methods of use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antigen delivery compositions and methods of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antigen delivery compositions and methods of use will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3855498

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.